Patent · US Active

Dihydroisoquinoline compound

US10717730B1 · kind B1 · utility

0Cited by

0References

6Claims

0Family size

Assignee

SUZHOU ARK BIOPHARMACEUTICAL CO., LTD. · CN

Inventors

Cheng PENG · Suzhou, CN
Yang Zhou · Suzhou, CN
Gang ZOU · Suzhou, CN
Danbin LI · Suzhou, CN
Haiqing Yuan · Irvine, US
Zhen Jim WU · Suzhou, CN
Xiashi LV · Suzhou, CN
Xiaogang LAI · Suzhou, CN
Shaoyun ZHANG · Suzhou, CN

Key dates

Filing date	Mar 11, 2020
Grant date	Jul 21, 2020
Priority date	—
Expiry date	Mar 11, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions containing the compound of general formula I: are disclosed. The compositions be used to prevent or treat hepatitis B virus infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.